Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Grows By 13.6%

Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 1,170,000 shares, a growth of 13.6% from the December 31st total of 1,030,000 shares. Currently, 1.4% of the shares of the company are short sold. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is presently 0.9 days.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in CLBT. Quarry LP purchased a new position in Cellebrite DI in the third quarter worth $27,000. Point72 Asia Singapore Pte. Ltd. lifted its holdings in Cellebrite DI by 59.6% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company's stock worth $33,000 after purchasing an additional 1,017 shares in the last quarter. Advisors Asset Management Inc. boosted its position in shares of Cellebrite DI by 130.5% in the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company's stock valued at $52,000 after acquiring an additional 1,742 shares during the period. Pathway Financial Advisers LLC increased its holdings in shares of Cellebrite DI by 1,583.8% in the third quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company's stock worth $74,000 after purchasing an additional 4,118 shares during the period. Finally, R Squared Ltd purchased a new stake in shares of Cellebrite DI in the 4th quarter valued at about $100,000. 45.88% of the stock is owned by institutional investors.

Cellebrite DI Trading Down 3.0 %

Cellebrite DI stock traded down $0.79 during midday trading on Thursday, reaching $25.21. The stock had a trading volume of 2,347,499 shares, compared to its average volume of 1,646,821. Cellebrite DI has a 12 month low of $8.91 and a 12 month high of $26.30. The company has a fifty day moving average price of $22.10 and a two-hundred day moving average price of $18.68. The company has a market capitalization of $5.19 billion, a P/E ratio of -16.26, a PEG ratio of 3.55 and a beta of 1.47.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.05. The firm had revenue of $106.90 million during the quarter, compared to analyst estimates of $102.06 million. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The company's revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.09 EPS. On average, equities research analysts predict that Cellebrite DI will post 0.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on CLBT shares. Craig Hallum raised their price objective on Cellebrite DI from $23.00 to $24.00 and gave the stock a "buy" rating in a research note on Thursday, November 7th. Needham & Company LLC raised their price target on shares of Cellebrite DI from $21.00 to $28.00 and gave the company a "buy" rating in a research note on Wednesday, January 22nd. Finally, JPMorgan Chase & Co. lifted their price objective on Cellebrite DI from $22.00 to $24.00 and gave the stock an "overweight" rating in a research note on Monday, December 16th. Eight analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $21.57.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.